Cargando…

Why does type 2 diabetes mellitus impair weight reduction in patients with obesity? A review

BACKGROUND: A common adiposopathic complication of obesity is type 2 diabetes mellitus. Healthful weight reduction in patients with obesity can improve glucose metabolism and potentially promote remission of type 2 diabetes mellitus. However, weight-reduction in patients with increased adiposity is...

Descripción completa

Detalles Bibliográficos
Autor principal:	Bays, Harold Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Clinical Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661899/ https://www.ncbi.nlm.nih.gov/pubmed/37990681 http://dx.doi.org/10.1016/j.obpill.2023.100076

Ejemplares similares

Obesity Pillars roundtable: Excessive weight reduction with highly effective anti-obesity medications (heAOMs)
por: Bays, Harold Edward, et al.
Publicado: (2022)

Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023
por: Bays, Harold Edward, et al.
Publicado: (2023)

Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus
por: Bays, Harold E
Publicado: (2014)

Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus
por: Bays, Harold E, et al.
Publicado: (2014)

Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Targeting the Kidney to Improve Glycemic Control in Diabetes Mellitus
por: Bays, Harold
Publicado: (2013)

Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients
por: Bays, Harold E
Publicado: (2012)

Weight-centric treatment of type 2 diabetes mellitus
por: Ghusn, Wissam, et al.
Publicado: (2022)

Obesity medicine as a subspecialty and United States certification – A review
por: Fitch, Angela, et al.
Publicado: (2023)

Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation
por: Cinkajzlová, Anna, et al.
Publicado: (2018)

Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Lazarus, Ethan, et al.
Publicado: (2022)

Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
por: Hollander, Priscilla, et al.
Publicado: (2013)

Omentin-1 plasma levels and cholesterol metabolism in obese patients with diabetes mellitus type 1: impact of weight reduction
por: Lesná, J, et al.
Publicado: (2015)

Diet-induced weight loss alters hepatic glucocorticoid metabolism in type 2 diabetes mellitus
por: Stomby, Andreas, et al.
Publicado: (2020)

The Evidence for an Obesity Paradox in Type 2 Diabetes Mellitus
por: Han, Seung Jin, et al.
Publicado: (2018)

Obesity Pillars Roundtable: Obesity and East Asians
por: Bays, Harold Edward, et al.
Publicado: (2022)

Efficacy of Body Weight Reduction on the SGLT2 Inhibitor in People with Type 2 Diabetes Mellitus
por: Cho, Hyun A, et al.
Publicado: (2017)

Impaired β Cell Function in Chinese Newly Diagnosed Type 2 Diabetes Mellitus with Hyperlipidemia
por: Ma, Yuhang, et al.
Publicado: (2014)

The DIAMOND system in the treatment of type 2 diabetes mellitus in an obese patient
por: Kozakowski, Jarosław, et al.
Publicado: (2014)

Obesity-related indices are associated with albuminuria and advanced kidney disease in type 2 diabetes mellitus
por: Ou, Yu-Lun, et al.
Publicado: (2021)

Insulin Therapy and Body Weight, Body Composition and Muscular Strength in Patients with Type 2 Diabetes Mellitus
por: Gin, H., et al.
Publicado: (2010)

Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Bays, Harold Edward, et al.
Publicado: (2022)

Insulin Therapy does not Interfere with Venous Endothelial Function Evaluation in Patients with Type 2 Diabetes Mellitus
por: da Silva, Antônio Marcos Vargas, et al.
Publicado: (2010)

Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
por: Kohan, Donald E, et al.
Publicado: (2014)

The Impact of Mindfulness-Based Stress Reduction on Emotional Wellbeing and Glycemic Control of Patients with Type 2 Diabetes Mellitus
por: Armani Kian, A., et al.
Publicado: (2018)

Perceived body image in men and women with type 2 diabetes mellitus: correlation of body mass index with the figure rating scale
por: Bays, Harold E, et al.
Publicado: (2009)

Selective Impairment of Attentional Networks of Executive Control in Middle-Aged Subjects with Type 2 Diabetes Mellitus
por: Hou, Dianlong, et al.
Publicado: (2018)

Obesity Pillars Roundtable: Obesity and South Asians
por: Bays, Harold Edward, et al.
Publicado: (2022)

Markers of Glucagon Resistance Improve With Reductions in Hepatic Steatosis and Body Weight in Type 2 Diabetes
por: Kjeldsen, Sasha A S, et al.
Publicado: (2023)

Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Tondt, Justin, et al.
Publicado: (2022)

Adiposopathy, “Sick Fat,” Ockham’s Razor, and Resolution of the Obesity Paradox
por: Bays, Harold
Publicado: (2014)

Normal-weight central obesity: implications for diabetes mellitus
por: Jin, Xueshan, et al.
Publicado: (2023)

Weight Loss with Sleeve Gastrectomy in Obese Type 2 Diabetes Mellitus: Impact on Cardiac Function
por: Leung, Melissa, et al.
Publicado: (2015)

Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions
por: Kratochvilova, Helena, et al.
Publicado: (2019)

Effect of Acupuncture on Body Weight Reduction and Inflammatory Mediators in Egyptian Obese Patients
por: Ismail, Laila Ahmed Abou, et al.
Publicado: (2015)

Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Karjoo, Sara, et al.
Publicado: (2022)

Metabolic effects of an entero-omentectomy in mildly obese type 2 diabetes mellitus patients after three years
por: Milleo, Fábio Quirilo, et al.
Publicado: (2011)

Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus
por: Shikora, S., et al.
Publicado: (2013)

Cognitive Impairment in Type 2 Diabetes Mellitus
por: Malik, Aimen, et al.
Publicado: (2022)

Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity
por: Bays, Harold E., et al.
Publicado: (2020)

A Retrospective Study of 6-Month Reduction in Risk of Developing Cardiovascular Diseases and Type 2 Diabetes Mellitus in Severely Obese Patients Over 60 Years of Age Following Bariatric Surgery
por: Domienik-Karłowicz, Justyna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u22p16i2rj6q8p3hbb0i10s86s